Assessing safety at the end of clinical trials using system organ classes: A case and comparative study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessing safety at the end of clinical trials using system organ classes: A case and comparative study

Published:2021-06-24 Issue:6 Volume:20 Page:1278-1287
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Carragher Raymond¹²³^ORCID,Robertson Chris²⁴

Affiliation:

1. Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde Glasgow UK

2. Department of Mathematics and Statistics University of Strathclyde Glasgow UK

3. Health Data Research (UK) University of Strathclyde Glasgow UK

4. Public Health Scotland NHS National Services Scotland Glasgow UK

Funder

Engineering and Physical Sciences Research Council

UK Research and Innovation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2148

Reference26 articles.

1. Flagging clinical adverse experiences: reducing false discoveries without materially compromising power for detecting true signals

2. False Discovery Rate Control With Groups

3. Accounting for Multiplicities in Assessing Drug Safety: A Three-Level Hierarchical Mixture Model

4. Multivariate Bayesian Logistic Regression for Analysis of Clinical Study Safety Issues

5. Bayesian Hierarchical Modeling for Detecting Safety Signals in Clinical Trials

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial;Frontiers in Immunology;2023-10-27

2. Updating the probability of study success for combination therapies using related combination study data;Statistical Methods in Medical Research;2023-02-12

3. Leveraging Machine Learning to Facilitate Individual Case Causality Assessment of Adverse Drug Reactions;Drug Safety;2022-05

4. Assessing safety at the end of clinical trials using system organ classes: A case and comparative study;Pharmaceutical Statistics;2021-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3